CSL · 19 hours ago
Senior Director, BD Transactions (1 of 2)
King of Prussia, PA
Full-time
Onsite
Director/ExecutiveCSL Behring is a global biotherapeutics leader driven by their promise to save lives. The Senior Director of Business Development Transactions will support the execution of complex partnering and acquisition deals, ensuring that CSL secures valuable partnerships while managing enterprise risk. This role requires leading transaction execution, shaping deal structures, and aligning cross-functional stakeholders to drive strategic outcomes.
BiotechnologyHealth CareHealth DiagnosticsMedical
Responsibilities
Lead execution of CSL’s high-priority licensing agreements, research collaborations, asset acquisitions, equity-linked deals and divestitures
Translate TA evaluation assumptions, due diligence findings and strategic intent into precise negotiation strategies, deal terms and execution plans
Shape deal structures, financial constructs and key contractual terms that balance scientific opportunity with commercial viability and risk tolerance
Partner closely with BD TA, Legal/IP and Finance to define defensible positions, valuation baselines, negotiation boundaries and fallback strategies
Working closely with BD TA, represent CSL as a senior negotiator in external partner discussions, ensuring alignment with enterprise priorities and long-term alliance success
Lead cross-functional diligence programs covering scientific, clinical, regulatory, commercial, CMC, supply, legal and operational domains
Ensure diligence findings directly inform deal shaping, risk mitigation and integration planning
Drive clarity and transparency of risks, assumptions and trade-offs for governance stakeholders
Prepare high-quality PRISM and senior leadership decision materials that clearly articulate deal rationale, valuation considerations, risks and strategic impact
Ensure all transactions adhere to CSL governance standards, compliance requirements and industry best practices
Facilitate timely decision-making by surfacing issues early and driving alignment across functions
Align stakeholders across R&D, Commercial, Technical Operations, Corporate Strategy, Finance and Enterprise Alliance Management
Drive enterprise judgement by ensuring rigorous debate, transparent trade-offs and alignment to long-range strategy
Collaborate with BD TA to ensure transaction structures reflect scientific and commercial assumptions
Ensure smooth transition of executed deals to Alliance Management and operational owners, including risk registers, obligations and communications
Provide early-life issue resolution support during the initial stabilisation period of partnerships and alliances
Mentor and guide more junior members of the team, strengthening CSL’s internal dealmaking capability
Contribute to developing tools, templates, negotiation frameworks and knowledge repositories that elevate the function
Drive a culture of discipline, strategic thinking, and deal quality across the BD Transactions team
Qualification
Required
Lead execution of CSL's high-priority licensing agreements, research collaborations, asset acquisitions, equity-linked deals and divestitures
Translate TA evaluation assumptions, due diligence findings and strategic intent into precise negotiation strategies, deal terms and execution plans
Shape deal structures, financial constructs and key contractual terms that balance scientific opportunity with commercial viability and risk tolerance
Partner closely with BD TA, Legal/IP and Finance to define defensible positions, valuation baselines, negotiation boundaries and fallback strategies
Working closely with BD TA, represent CSL as a senior negotiator in external partner discussions, ensuring alignment with enterprise priorities and long-term alliance success
Lead cross-functional diligence programs covering scientific, clinical, regulatory, commercial, CMC, supply, legal and operational domains
Ensure diligence findings directly inform deal shaping, risk mitigation and integration planning
Drive clarity and transparency of risks, assumptions and trade-offs for governance stakeholders
Prepare high-quality PRISM and senior leadership decision materials that clearly articulate deal rationale, valuation considerations, risks and strategic impact
Ensure all transactions adhere to CSL governance standards, compliance requirements and industry best practices
Facilitate timely decision-making by surfacing issues early and driving alignment across functions
Align stakeholders across R&D, Commercial, Technical Operations, Corporate Strategy, Finance and Enterprise Alliance Management
Drive enterprise judgement by ensuring rigorous debate, transparent trade-offs and alignment to long-range strategy
Collaborate with BD TA to ensure transaction structures reflect scientific and commercial assumptions
Ensure smooth transition of executed deals to Alliance Management and operational owners, including risk registers, obligations and communications
Provide early-life issue resolution support during the initial stabilisation period of partnerships and alliances
Mentor and guide more junior members of the team, strengthening CSL's internal dealmaking capability
Contribute to developing tools, templates, negotiation frameworks and knowledge repositories that elevate the function
Drive a culture of discipline, strategic thinking, and deal quality across the BD Transactions team
Company
CSL
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
Founded in 1916
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$111M2013-12-20Acquired
2004-02-06Post Ipo Equity· $111M
1994-06-03IPO
Leadership Team
Jeffrey Ball
Chief Sustainability Officer
Joy Linton
Strategic Advisor
Recent News
Pharma Letter
2026-01-03
2025-10-29
Company data provided by crunchbase